Cross talk between mitochondria and NADPH oxidases

Hamanaka, 2010, Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes, Trends Biochem. Sci., 35, 505, 10.1016/j.tibs.2010.04.002

Lassegue, 2009, NADPH oxidases: functions and pathologies in the vasculature, Arterioscler. Thromb. Vasc. Biol., 30, 653, 10.1161/ATVBAHA.108.181610

Clempus, 2007, Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype, Arterioscler. Thromb. Vasc. Biol., 27, 42, 10.1161/01.ATV.0000251500.94478.18

Ushio-Fukai, 2001, Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 21, 489, 10.1161/01.ATV.21.4.489

Griendling, 2000, Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology, Arterioscler. Thromb. Vasc. Biol., 20, 2175, 10.1161/01.ATV.20.10.2175

Cai, 2003, Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide, Mol. Pharmacol., 63, 325, 10.1124/mol.63.2.325

Irrcher, 2009, Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells, Am. J. Physiol. Cell Physiol., 296, C116, 10.1152/ajpcell.00267.2007

Kim, 2007, Effects of PGC-1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cells, Antioxid. Redox Signal., 9, 301, 10.1089/ars.2006.1456

Lee, 2000, Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite, J. Biol. Chem., 275, 38965, 10.1074/jbc.M006341200

Carey, 2005, Update on the role of the AT2 receptor, Curr. Opin. Nephrol. Hypertens., 14, 67, 10.1097/00041552-200501000-00011

Ohashi, 2006, MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice, Arterioscler. Thromb. Vasc. Biol., 26, 2331, 10.1161/01.ATV.0000238347.77590.c9

Harrison, 2003, Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease, J. Renin Angiotensin Aldosterone Syst., 4, 51, 10.3317/jraas.2003.014

Harrison, 2007, Oxidative stress and hypertension, J. Am. Soc. Hypertens., 1, 30, 10.1016/j.jash.2006.11.006

Sadek, 2003, Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function, Arch. Biochem. Biophys., 420, 201, 10.1016/j.abb.2003.09.029

Franco, 2008, Oxidative stress, DNA methylation and carcinogenesis, Cancer Lett., 266, 6, 10.1016/j.canlet.2008.02.026

Fridovich, 2004, Mitochondria: are they the seat of senescence?, Aging Cell, 3, 13, 10.1046/j.1474-9728.2003.00075.x

Beal, 1996, Mitochondria, free radicals, and neurodegeneration, Curr. Opin. Neurobiol., 6, 661, 10.1016/S0959-4388(96)80100-0

Griendling, 2000, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ. Res., 86, 494, 10.1161/01.RES.86.5.494

Spiekermann, 2003, Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation, Circulation, 107, 1383, 10.1161/01.CIR.0000056762.69302.46

Landmesser, 2003, Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension, J. Clin. Invest., 111, 1201, 10.1172/JCI200314172

Dikalova, 2010, Therapeutic targeting of mitochondrial superoxide in hypertension, Circ. Res., 107, 106, 10.1161/CIRCRESAHA.109.214601

Li, 2001, H2O2-induced O2 production by a non-phagocytic NAD(P)H oxidase causes oxidant injury, J. Biol. Chem., 276, 29251, 10.1074/jbc.M102124200

Kuzkaya, 2003, Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase, J. Biol. Chem., 278, 22546, 10.1074/jbc.M302227200

Radi, 2002, Peroxynitrite reactions and formation in mitochondria, Free Radic. Biol. Med., 33, 1451, 10.1016/S0891-5849(02)01111-5

McNally, 2005, Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium, Arterioscler. Thromb. Vasc. Biol., 25, 1623, 10.1161/01.ATV.0000170827.16296.6e

Cadenas, 2000, Mitochondrial free radical generation, oxidative stress, and aging, Free Radic. Biol. Med., 29, 222, 10.1016/S0891-5849(00)00317-8

Chance, 1955, Respiratory enzymes in oxidative phosphorylation. III. The steady state, J. Biol. Chem., 217, 409, 10.1016/S0021-9258(19)57191-5

Boveris, 1984, Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria, Methods Enzymol., 105, 429, 10.1016/S0076-6879(84)05060-6

Han, 2003, Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol, J. Biol. Chem., 278, 5557, 10.1074/jbc.M210269200

Cadenas, 1977, Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol–cytochrome c reductase from beef-heart mitochondria, Arch. Biochem. Biophys., 180, 248, 10.1016/0003-9861(77)90035-2

Han, 2001, Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space, Biochem. J., 353, 411, 10.1042/bj3530411

Starkov, 2004, Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species, J. Neurosci., 24, 7779, 10.1523/JNEUROSCI.1899-04.2004

Brand, 2010, The sites and topology of mitochondrial superoxide production, Exp. Gerontol., 45, 466, 10.1016/j.exger.2010.01.003

St-Pierre, 2002, Topology of superoxide production from different sites in the mitochondrial electron transport chain, J. Biol. Chem., 277, 44784, 10.1074/jbc.M207217200

Tahara, 2009, Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation, Free Radic. Biol. Med., 46, 1283, 10.1016/j.freeradbiomed.2009.02.008

Gutterman, 2005, Mitochondria and reactive oxygen species: an evolution in function, Circ. Res., 97, 302, 10.1161/01.RES.0000179773.18195.12

Brookes, 2002, Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species, Free Radic. Biol. Med., 33, 755, 10.1016/S0891-5849(02)00901-2

McBride, 2006, Mitochondria: more than just a powerhouse, Curr. Biol., 16, R551, 10.1016/j.cub.2006.06.054

Ackrell, 1974, Role of oxalacetate in the regulation of mammalian succinate dehydrogenase, J. Biol. Chem., 249, 2021, 10.1016/S0021-9258(19)42790-7

Lambert, 2008, Diphenyleneiodonium acutely inhibits reactive oxygen species production by mitochondrial complex I during reverse, but not forward electron transport, Biochim. Biophys. Acta, 1777, 397, 10.1016/j.bbabio.2008.03.005

Lambert, 2004, Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane, Biochem. J., 382, 511, 10.1042/BJ20040485

Doughan, 2008, Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction, Circ. Res., 102, 488, 10.1161/CIRCRESAHA.107.162800

Andrukhiv, 2006, Opening mitoKATP increases superoxide generation from complex I of the electron transport chain, Am. J. Physiol. Heart Circ. Physiol., 291, H2067, 10.1152/ajpheart.00272.2006

Queliconi, 2011, Redox regulation of the mitochondrial K(ATP) channel in cardioprotection, Biochim. Biophys. Acta, 1813, 1309, 10.1016/j.bbamcr.2010.11.005

Costa, 2008, Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT, Am. J. Physiol. Heart Circ. Physiol., 295, H874, 10.1152/ajpheart.01189.2007

Piskernik, 2008, Antimycin A and lipopolysaccharide cause the leakage of superoxide radicals from rat liver mitochondria, Biochim. Biophys. Acta, 1782, 280, 10.1016/j.bbadis.2008.01.007

Panov, 2009, The neuromediator glutamate, through specific substrate interactions, enhances mitochondrial ATP production and reactive oxygen species generation in nonsynaptic brain mitochondria, J. Biol. Chem., 284, 14448, 10.1074/jbc.M900985200

Kudin, 2008, Sites of generation of reactive oxygen species in homogenates of brain tissue determined with the use of respiratory substrates and inhibitors, Biochim. Biophys. Acta, 1777, 689, 10.1016/j.bbabio.2008.05.010

Nishikawa, 2007, Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications, Antioxid. Redox Signal., 9, 343, 10.1089/ars.2006.1458

Powell, 2003, Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia–reoxygenation: modulation of enzyme activities by MnSOD, Am. J. Physiol. Lung Cell. Mol. Physiol., 285, L189, 10.1152/ajplung.00253.2002

Quijano, 2001, Reaction of peroxynitrite with Mn-superoxide dismutase: role of the metal center in decomposition kinetics and nitration, J. Biol. Chem., 276, 11631, 10.1074/jbc.M009429200

Wu, 2008, L-malate reverses oxidative stress and antioxidative defenses in liver and heart of aged rats, Physiol. Res., 57, 261, 10.33549/physiolres.931161

Shatrov, 2003, Induced expression of manganese superoxide dismutase by non-toxic concentrations of oxidized low-density lipoprotein (oxLDL) protects against oxLDL-mediated cytotoxicity, Biochem. J., 374, 505, 10.1042/bj20030420

Reddy, 2004, Effects of variation in superoxide dismutases (SOD) on oxidative stress and apoptosis in lens epithelium, Exp. Eye Res., 79, 859, 10.1016/j.exer.2004.04.005

Jang, 2009, Overexpression of Mn superoxide dismutase does not increase life span in mice, J. Gerontol. A Biol. Sci. Med. Sci., 64, 1114, 10.1093/gerona/glp100

Ballinger, 2005, Mitochondrial dysfunction in cardiovascular disease, Free Radic. Biol. Med., 38, 1278, 10.1016/j.freeradbiomed.2005.02.014

Liu, 2003, Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries, Circ. Res., 93, 573, 10.1161/01.RES.0000091261.19387.AE

Yakes, 1997, Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress, Proc. Natl. Acad. Sci. U.S.A., 94, 514, 10.1073/pnas.94.2.514

Ballinger, 2000, Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells, Circ. Res., 86, 960, 10.1161/01.RES.86.9.960

Chen, 2002, Protein oxidation of cytochrome C by reactive halogen species enhances its peroxidase activity, J. Biol. Chem., 277, 29781, 10.1074/jbc.M200709200

Brookes, 2001, Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy, J. Mol. Cell. Cardiol., 33, 69, 10.1006/jmcc.2000.1276

MacMillan-Crow, 2001, Mitochondrial tyrosine nitration precedes chronic allograft nephropathy, Free Radic. Biol. Med., 31, 1603, 10.1016/S0891-5849(01)00750-X

Panov, 2005, Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication, J. Biol. Chem., 280, 42026, 10.1074/jbc.M508628200

Swerdlow, 2007, Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem, Antioxid. Redox Signal., 9, 1591, 10.1089/ars.2007.1676

Schulze-Osthoff, 1995, Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes, Biochem. Pharmacol., 50, 735, 10.1016/0006-2952(95)02011-Z

Chen, 2004, Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling, J. Biol. Chem., 279, 35079, 10.1074/jbc.M404859200

Shen, 2006, Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy, Diabetes, 55, 798, 10.2337/diabetes.55.03.06.db05-1039

Matsushima, 2006, Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice, Circulation, 113, 1779, 10.1161/CIRCULATIONAHA.105.582239

Banmeyer, 2005, Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide, FEBS Lett., 579, 2327, 10.1016/j.febslet.2005.03.027

Ernster, 1992, The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles, Biofactors, 3, 241

Murphy, 2000, Drug delivery to mitochondria: the key to mitochondrial medicine, Adv. Drug Deliv. Rev., 41, 235, 10.1016/S0169-409X(99)00069-1

Kagan, 2009, Mitochondrial targeting of electron scavenging antioxidants: regulation of selective oxidation vs random chain reactions, Adv. Drug Deliv. Rev., 61, 1375, 10.1016/j.addr.2009.06.008

Trnka, 2008, A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria, Free Radic. Biol. Med., 44, 1406, 10.1016/j.freeradbiomed.2007.12.036

Skulachev, 2007, A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects, Biochemistry (Moscow), 72, 1385, 10.1134/S0006297907120139

Dikalov, 1997, Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants, Biochem. Biophys. Res. Commun., 231, 701, 10.1006/bbrc.1997.6174

Trnka, 2009, Antioxidant properties of MitoTEMPOL and its hydroxylamine, Free Radic. Res., 43, 4, 10.1080/10715760802582183

Dhanasekaran, 2005, Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide, Free Radic. Biol. Med., 39, 567, 10.1016/j.freeradbiomed.2005.04.016

Murphy, 2007, Targeting antioxidants to mitochondria by conjugation to lipophilic cations, Annu. Rev. Pharmacol. Toxicol., 47, 629, 10.1146/annurev.pharmtox.47.120505.105110

O'Malley, 2006, Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria, J. Biol. Chem., 281, 39766, 10.1074/jbc.M608268200

Doughan, 2007, Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis, Antioxid. Redox Signal., 9, 1825, 10.1089/ars.2007.1693

Namiecinski, 2004, Cytotoxicity, cytoprotection and neurotoxicity of novel deprenyl-related propargylamines, stable nitroxide free radicals, in vitro and in vivo, In Vivo, 18, 171

Mildaziene, 1997, Tetraphenylphosphonium inhibits oxidation of physiological substrates in heart mitochondria, Mol. Cell. Biochem., 174, 67, 10.1023/A:1006812128286

Szeto, 2006, Cell-permeable, mitochondrial-targeted, peptide antioxidants, AAPS J., 8, E277, 10.1007/BF02854898

Rocha, 2010, Mitochondria-targeted antioxidant peptides, Curr. Pharm. Des., 16, 3124, 10.2174/138161210793292519

Fink, 2007, Hemigramicidin–TEMPO conjugates: novel mitochondria-targeted antioxidants, Crit. Care Med., 35, S461, 10.1097/01.CCM.0000279192.96303.E7

Bedard, 2007, The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology, Physiol. Rev., 87, 245, 10.1152/physrev.00044.2005

Lassegue, 2003, Vascular NAD(P)H oxidases: specific features, expression, and regulation, Am. J. Physiol. Regul. Integr. Comp. Physiol., 285, R277, 10.1152/ajpregu.00758.2002

Gorlach, 2000, A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall, Circ. Res., 87, 26, 10.1161/01.RES.87.1.26

Jones, 1996, Expression of phagocyte NADPH oxidase components in human endothelial cells, Am. J. Physiol., 271, H1626

Touyz, 2002, Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II, Circ. Res., 90, 1205, 10.1161/01.RES.0000020404.01971.2F

Wang, 1998, Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide, Circ. Res., 82, 810, 10.1161/01.RES.82.7.810

Ago, 2004, Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase, Circulation, 109, 227, 10.1161/01.CIR.0000105680.92873.70

Hilenski, 2004, Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 24, 677, 10.1161/01.ATV.0000112024.13727.2c

Brown, 2009, Nox proteins in signal transduction, Free Radic. Biol. Med., 47, 1239, 10.1016/j.freeradbiomed.2009.07.023

Dikalov, 2008, Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production, Free Radic. Biol. Med., 45, 1340, 10.1016/j.freeradbiomed.2008.08.013

Takac, 2011, The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4, J. Biol. Chem., 286, 13304, 10.1074/jbc.M110.192138

Guzik, 2008, Calcium-dependent NOX5 NADPH oxidase contributes to vascular oxidative stress in human coronary artery disease, J. Am. Coll. Cardiol., 52, 10.1016/j.jacc.2008.07.063

Block, 2009, Subcellular localization of Nox4 and regulation in diabetes, Proc. Natl. Acad. Sci. U.S.A., 106, 14385, 10.1073/pnas.0906805106

Kuroda, 2010, NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart, Proc. Natl. Acad. Sci. U.S.A., 107, 15565, 10.1073/pnas.1002178107

Ago, 2010, Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes, Circ. Res., 106, 1253, 10.1161/CIRCRESAHA.109.213116

Lyle, 2009, Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells, Circ. Res., 105, 249, 10.1161/CIRCRESAHA.109.193722

Zhang, 2010, NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis, Proc. Natl. Acad. Sci. U.S.A., 107, 18121, 10.1073/pnas.1009700107

Lavoie, 2003, Overview of the renin–angiotensin system—an endocrine and paracrine system, Endocrinology, 144, 2179, 10.1210/en.2003-0150

Seshiah, 2002, Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators, Circ. Res., 91, 406, 10.1161/01.RES.0000033523.08033.16

Martyn, 2006, Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases, Cell. Signal., 18, 69, 10.1016/j.cellsig.2005.03.023

Lassegue, 2001, Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways, Circ. Res., 88, 888, 10.1161/hh0901.090299

Bendall, 2007, Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice, Circ. Res., 100, 1016, 10.1161/01.RES.0000263381.83835.7b

Park, 2008, Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat, J. Korean Med. Sci., 23, 1039, 10.3346/jkms.2008.23.6.1039

DeMarco, 2008, Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat, Am. J. Physiol. Heart Circ. Physiol., 294, H2659, 10.1152/ajpheart.00953.2007

Rey, 2001, Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2− and systolic blood pressure in mice, Circ. Res., 89, 408, 10.1161/hh1701.096037

de Cavanagh, 2003, Enalapril and losartan attenuate mitochondrial dysfunction in aged rats, FASEB J., 17, 1096, 10.1096/fj.02-0063fje

de Cavanagh, 2006, Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine, Am. J. Physiol. Regul. Integr. Comp. Physiol., 290, R1616, 10.1152/ajpregu.00615.2005

Monteiro, 2005, Valsartan improves mitochondrial function in hearts submitted to acute ischemia, Eur. J. Pharmacol., 518, 158, 10.1016/j.ejphar.2005.06.013

Mehta, 2007, Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am. J. Physiol. Cell Physiol., 292, C82, 10.1152/ajpcell.00287.2006

Kimura, 2005, Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide, Hypertension, 45, 438, 10.1161/01.HYP.0000157169.27818.ae

Kimura, 2005, Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II, Hypertension, 45, 860, 10.1161/01.HYP.0000163462.98381.7f

Zhang, 2001, Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels, Circ. Res., 89, 1177, 10.1161/hh2401.101752

Costa, 2006, The direct physiological effects of mitoK(ATP) opening on heart mitochondria, Am. J. Physiol. Heart Circ. Physiol., 290, H406, 10.1152/ajpheart.00794.2005

Lee, 2006, Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death, J. Biol. Chem., 281, 36228, 10.1074/jbc.M606702200

Wosniak, 2009, Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells, Antioxid. Redox Signal., 11, 1265, 10.1089/ars.2009.2392

Daiber, 2010, Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species, Biochim. Biophys. Acta, 1797, 897, 10.1016/j.bbabio.2010.01.032

Rathore, 2008, Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS–PKCε signaling axis in pulmonary artery smooth muscle cells, Free Radic. Biol. Med., 45, 1223, 10.1016/j.freeradbiomed.2008.06.012

Wenzel, 2008, First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction, Antioxid. Redox Signal., 10, 1435, 10.1089/ars.2007.1969

Boulden, 2006, Early determinants of H2O2-induced endothelial dysfunction, Free Radic. Biol. Med., 41, 810, 10.1016/j.freeradbiomed.2006.05.030

Santos, 2009, Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase, Antioxid. Redox Signal., 11, 2409, 10.1089/ars.2009.2625

Wang, 2002, Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II, Am. J. Physiol. Heart Circ. Physiol., 282, H1697, 10.1152/ajpheart.00914.2001

Dikalova, 2005, Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice, Circulation, 112, 2668, 10.1161/CIRCULATIONAHA.105.538934

Laursen, 1997, Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension, Circulation, 95, 588, 10.1161/01.CIR.95.3.588

Landmesser, 2002, Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II, Hypertension, 40, 511, 10.1161/01.HYP.0000032100.23772.98

Widder, 2009, Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of thioredoxin 2, Hypertension, 54, 338, 10.1161/HYPERTENSIONAHA.108.127928

Rodriguez-Iturbe, 2007, Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence, J. Appl. Physiol., 102, 255, 10.1152/japplphysiol.00513.2006

Madamanchi, 2007, Mitochondrial dysfunction in atherosclerosis, Circ. Res., 100, 460, 10.1161/01.RES.0000258450.44413.96

Patel, 2000, Cell signaling by reactive nitrogen and oxygen species in atherosclerosis, Free Radic. Biol. Med., 28, 1780, 10.1016/S0891-5849(00)00235-5

Cai, 2003, The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases, Trends Pharmacol. Sci., 24, 471, 10.1016/S0165-6147(03)00233-5

Victor, 2009, Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy, Curr. Med. Chem., 16, 4654, 10.2174/092986709789878265

Garbe, 2011, Systematic review of medical treatment in melanoma: current status and future prospects, Oncologist, 16, 5, 10.1634/theoncologist.2010-0190

Khandrika, 2009, Oxidative stress in prostate cancer, Cancer Lett., 282, 125, 10.1016/j.canlet.2008.12.011

Brar, 2002, An NAD(P)H oxidase regulates growth and transcription in melanoma cells, Am. J. Physiol. Cell Physiol., 282, C1212, 10.1152/ajpcell.00496.2001

Ushio-Fukai, 2008, Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy, Cancer Lett., 266, 37, 10.1016/j.canlet.2008.02.044

Desouki, 2005, Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors, Cancer Biol. Ther., 4, 1367, 10.4161/cbt.4.12.2233

Huang, 1997, Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5′ CpG island, Free Radic. Biol. Med., 23, 314, 10.1016/S0891-5849(97)00095-6

Murley, 2011, SOD2-mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells, Radiat. Res., 175, 57, 10.1667/RR2349.1

Jiang, 2009, A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator, Radiat. Res., 172, 706, 10.1667/RR1729.1

Gao, 2009, Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling, Cardiovasc. Res., 82, 9, 10.1093/cvr/cvp031

Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615

Thallas-Bonke, 2008, Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway, Diabetes, 57, 460, 10.2337/db07-1119

Bugger, 2010, Mitochondria in the diabetic heart, Cardiovasc. Res., 88, 229, 10.1093/cvr/cvq239

Quast, 2004, The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium, Diabetes, 53, S156, 10.2337/diabetes.53.suppl_3.S156

Pomerantz, 2000, Selective mitochondrial KATP channel opening controls human myocardial preconditioning: too much of a good thing?, Surgery, 128, 368, 10.1067/msy.2000.107423

Glade, 2010, Oxidative stress and cognitive longevity, Nutrition, 26, 595, 10.1016/j.nut.2009.09.014

Loft, 1994, Oxidative DNA damage correlates with oxygen consumption in humans, FASEB J., 8, 534, 10.1096/fasebj.8.8.8181672

Smith, 2002, Cerebral energetics and spiking frequency: the neurophysiological basis of fMRI, Proc. Natl. Acad. Sci. U.S.A., 99, 10765, 10.1073/pnas.132272199

Panov, 1999, Ca2+-dependent permeability transition and complex I activity in lymphoblast mitochondria from normal individuals and patients with Huntington's or Alzheimer's disease, Ann. N. Y. Acad. Sci., 893, 365, 10.1111/j.1749-6632.1999.tb07856.x

Greenamyre, 2001, Complex I and Parkinson's disease, IUBMB Life, 52, 135, 10.1080/15216540152845939

Block, 2008, NADPH oxidase as a therapeutic target in Alzheimer's disease, BMC Neurosci., 9, S8, 10.1186/1471-2202-9-S2-S8

Park, 2005, NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide, J. Neurosci., 25, 1769, 10.1523/JNEUROSCI.5207-04.2005

Wilkinson, 2006, The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease, J. Neuroinflammation, 3, 30, 10.1186/1742-2094-3-30

Head, 2009, Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain aging, Neurochem. Res., 34, 670, 10.1007/s11064-008-9808-4

Stefanova, 2010, Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats, J. Alzheimers Dis., 21, 479, 10.3233/JAD-2010-091675

Harman, 1972, The biologic clock: the mitochondria?, J. Am. Geriatr. Soc., 20, 145, 10.1111/j.1532-5415.1972.tb00787.x

Beckman, 1998, The free radical theory of aging matures, Physiol. Rev., 78, 547, 10.1152/physrev.1998.78.2.547

Gems, 2008, Stress-response hormesis and aging: "that which does not kill us makes us stronger.", Cell Metab., 7, 200, 10.1016/j.cmet.2008.01.001

Conley, 2007, Mitochondrial dysfunction and age, Curr. Opin. Clin. Nutr. Metab. Care, 10, 688, 10.1097/MCO.0b013e3282f0dbfb

Krause, 2007, Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases, Exp. Gerontol., 42, 256, 10.1016/j.exger.2006.10.011

Benigni, 2010, Angiotensin II revisited: new roles in inflammation, immunology and aging, EMBO Mol. Med., 2, 247, 10.1002/emmm.201000080

Akki, 2009, NADPH oxidase signaling and cardiac myocyte function, J. Mol. Cell. Cardiol., 47, 15, 10.1016/j.yjmcc.2009.04.004

Bendall, 2002, Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice, Circulation, 105, 293, 10.1161/hc0302.103712

Hool, 2007, Redox control of calcium channels: from mechanisms to therapeutic opportunities, Antioxid. Redox Signal., 9, 409, 10.1089/ars.2006.1446

Liu, 2010, Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel, Circ. Res., 107, 967, 10.1161/CIRCRESAHA.110.220673

Dai, 2011, Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and G{alpha}q overexpression-induced heart failure, Circ. Res., 108, 837, 10.1161/CIRCRESAHA.110.232306

Crespo, 2010, Mitochondrial reactive oxygen species mediate cardiomyocyte formation from embryonic stem cells in high glucose, Stem Cells, 28, 1132, 10.1002/stem.441

Deng, 2010, Endothelin signalling regulates volume-sensitive Cl− current via NADPH oxidase and mitochondrial reactive oxygen species, Cardiovasc. Res., 88, 93, 10.1093/cvr/cvq125

O'Connor, 2010, Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria, Circ. Res., 107, 9, 10.1161/CIRCRESAHA.110.223321

de Cavanagh, 2007, From mitochondria to disease: role of the renin–angiotensin system, Am. J. Nephrol., 27, 545, 10.1159/000107757